Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia

BACKGROUND: Early-onset dementia patients often present with atypical clinical symptoms, hampering an accurate clinical diagnosis. The purpose of the present study was to assess the diagnostic impact of the amyloid-positron emission tomography (PET) imaging agent [(18)F]flutemetamol in early-onset d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwan, Marissa D., Bouwman, Femke H., Konijnenberg, Elles, van der Flier, Wiesje M., Lammertsma, Adriaan A., Verhey, Frans R. J., Aalten, Pauline, van Berckel, Bart N. M., Scheltens, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240413/
https://www.ncbi.nlm.nih.gov/pubmed/28093088
http://dx.doi.org/10.1186/s13195-016-0228-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240413/
https://www.ncbi.nlm.nih.gov/pubmed/28093088
http://dx.doi.org/10.1186/s13195-016-0228-4

Ejemplares similares